Cytokinetics

Cardiovascular Account Specialist - U.S. Sales, Brooklyn, NY

Remote

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Position Overview

  • Location Type: Territory-Based (Includes Staten Island, NY)
  • Employment Type: Full Time
  • Salary: (Salary not provided)
  • Company: Cytokinetics

Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. The company is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility. This role focuses on launching a novel cardiac myosin inhibitor for Hypertrophic Cardiomyopathy (HCM) within a designated territory.

Responsibilities

  • Drive Sales Results: Achieve sales targets and operate autonomously within the assigned territory.
  • Territory Account Planning: Develop and execute territory-specific account plans to identify, assess, and prioritize opportunities.
  • Integrated Field Team Collaboration: Work synergistically with internal stakeholders (medical, payer, patient navigation/support) to meet customer needs.
  • Subject Matter Expert: Serve as a resource for customers, providing clinically relevant disease and product information.
  • Demand Generation: Communicate approved resources to healthcare professionals (HCPs) to create demand for the product launch, including:
    • Marketing materials
    • Payer information
    • Formulary coverage
    • Patient support services
    • Educational programs

Requirements

  • Education: Bachelor’s Degree required.
  • Experience: 5+ years of experience in biotech/pharma sales.
  • Territory Ownership: Preference for experience as a rep with sole ownership of the territory.
  • Preferred Experience:
    • Cardiology, rare disease, or specialty product experience.
    • Specialty product launch experience.
    • Patient experience.

Application Instructions

  • (Application instructions not provided)

Company Information

Cytokinetics’ core values include:

  • Patients are our North Star: Dedicated to benefiting patients and their caregivers.
  • Science is in our Soul: Committed to scientific excellence, integrity, and critical thinking.
  • We > Me: Strength lies in unity and diversity.
  • Make it Happen: Tenacity, resilience, and delivering impactful results.

Skills

Biotech sales
Pharmaceutical sales
Cardiology
Rare disease
Specialty product launch
Account planning
Customer relationship management
Demand generation
Educational programs
Payer and formulary knowledge

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Risks

Increased competition could impact market share and profitability.
Potential delays in clinical trials could hinder drug commercialization.
Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
The company has a robust pipeline including omecamtiv mecarbil and aficamten.
Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.
Strategic partnerships, like with Sanofi, expand market reach and potential revenue.
Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI